Q4 2022 Holdings
Filed 2023-02-09 | 26 holdings | $267.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences, Inc. | COM | 010392595 | $49.3M | 6,708,288 | 18.5% |
| Zentalis Pharmaceuticals Inc.(ZNTL) | COM | 98943L107 | $36.7M | 1,824,583 | 13.8% |
| Prometheus Biosciences, Inc. | COM | 74349U108 | $27.5M | 250,000 | 10.3% |
| Cue Health Inc.(HLTHQ) | COM | 229790100 | $18.6M | 8,980,909 | 7.0% |
| Arcus BioSciences, Inc.(RCUS) | COM | 03969F109 | $18.0M | 869,790 | 6.7% |
| Illumnia, Inc.(ILMN) | COM | 452327109 | $16.3M | 80,859 | 6.1% |
| Albireo Pharma, Inc.(BDQM) | COM | 01345P106 | $13.5M | 623,342 | 5.0% |
| 10x Genomics, Inc.(TXG) | CL A COM | 88025U109 | $13.1M | 359,554 | 4.9% |
| Pacific Biosciences of California, Inc.(PACB) | COM | 69404D108 | $12.0M | 1,463,872 | 4.5% |
| BeyondSpring Inc. | SHS | 00BD36JB9 | $9.3M | 4,958,143 | 3.5% |
| Horizon Therapeutics PLC | COM | G46188101 | $9.0M | 78,900 | 3.4% |
| Terns Pharmaceuticals, Inc.(TERN) | COM | 880881107 | $7.3M | 714,285 | 2.7% |
| Aadi Bioscience, Inc.(WHWK) | COM | 00032Q104 | $6.8M | 526,329 | 2.5% |
| Mersana Therapeutics, Inc. | COM | 59045L106 | $5.3M | 904,268 | 2.0% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $5.2M | 580,000 | 1.9% |
| Equillium Inc.(EQ) | COM | 29446K106 | $4.9M | 4,447,308 | 1.8% |
| Aura Biosciences, Inc.(AURA) | COM | 05153U107 | $3.1M | 293,333 | 1.2% |
| Seagen Inc. | COM | 812578102 | $3.0M | 23,014 | 1.1% |
| Argenx SE(ARGX) | SHS | 04016X101 | $2.1M | 5,529 | 0.8% |
| AtriCure Inc. | COM | 004963C20 | $2.1M | 46,259 | 0.8% |
| Apexigen, Inc. | COM | 03759B102 | $1.3M | 1,894,551 | 0.5% |
| GeneDx Holdings Corp.(SMFRUSD) | COM CL A | 81663L101 | $902.6K | 3,418,929 | 0.3% |
| Scynexis Inc.(SCYX) | COM NEW | 811292200 | $866.7K | 555,555 | 0.3% |
| Nautilus Biotechnology, Inc.(NAUT) | COM | 63909J108 | $540.0K | 300,000 | 0.2% |
| Owlet, Inc. | COM CL A | 69120X107 | $502.3K | 898,400 | 0.2% |
| NeuBase Therapeutics, Inc. | COM | 64132K102 | $190.2K | 1,000,000 | 0.1% |